{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T01:22:48Z","timestamp":1781227368121,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","cmghjournal.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.jcmgh.2023.10.003","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T19:33:54Z","timestamp":1698089634000},"page":"219-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Oncostatin M Induces IFITM1 Expression to Inhibit Hepatitis B Virus Replication Via JAK-STAT Signaling"],"prefix":"10.1016","volume":"17","author":[{"given":"Yuchen","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caorui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunfang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songhang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Xun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9923-3212","authenticated-orcid":false,"given":"Qishui","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2023.10.003_bib1","unstructured":"Collaborators. PO. HBV progress towards coverage targets. 2021. 10-04\/2022-02-06 http:\/\/cdafound.org\/polaris-countries-dashboard\/. Accessed 2019."},{"key":"10.1016\/j.jcmgh.2023.10.003_bib2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2468-1253(19)30119-0","article-title":"A\u00a0global scientific strategy to cure hepatitis B","volume":"4","author":"Revill","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/hep.32314","article-title":"Getting to HBV cure: the promising paths forward","volume":"76","author":"Fung","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib4","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jhep.2021.05.013","article-title":"Covalently closed circular DNA: the ultimate therapeutic target for curing HBV infections","volume":"75","author":"Martinez","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib5","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/gutjnl-2018-316641","article-title":"Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load","volume":"68","author":"Schuch","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib6","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jhep.2016.12.024","article-title":"Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B","volume":"66","author":"Lebosse","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib7","first-page":"125","article-title":"Hepatitis B gene therapy coming to age","volume":"20","author":"Soriano","year":"2018","journal-title":"AIDS Rev"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib8","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jhep.2017.12.007","article-title":"Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism","volume":"68","author":"Niu","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib9","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41392-021-00776-0","article-title":"Restoration of HBV-specific CD8(+) T-cell responses by sequential low-dose IL-2 treatment in non-responder patients after IFN-alpha therapy","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib10","doi-asserted-by":"crossref","first-page":"a028415","DOI":"10.1101\/cshperspect.a028415","article-title":"Interleukin-6 family cytokines","volume":"10","author":"Rose-John","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib11","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/hep.23226","article-title":"Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection","volume":"50","author":"Hosel","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib12","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jhep.2013.10.016","article-title":"Characterization of the CD40L\/oncostatin M\/oncostatin M receptor axis as an antiviral and immunostimulatory system disrupted in chronic HCV infection","volume":"60","author":"Larrea","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib13","doi-asserted-by":"crossref","first-page":"7578","DOI":"10.1096\/fj.201801563R","article-title":"Cardiotrophin-1 is an anti-inflammatory cytokine and promotes IL-4-induced M2 macrophage polarization","volume":"33","author":"Carneros","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib14","article-title":"IL6 inhibits HBV transcription by targeting the epigenetic control of the nuclear cccDNA minichromosome","volume":"10","author":"Palumbo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib15","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1128\/JVI.02167-08","article-title":"Oncostatin M enhances the antiviral effects of type I interferon and activates immunostimulatory functions in liver epithelial cells","volume":"83","author":"Larrea","year":"2009","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib16","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/gutjnl-2012-304377","article-title":"Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes","volume":"63","author":"Larrea","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41575-021-00473-x","article-title":"New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology","volume":"18","author":"Giraldez","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib18","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.3390\/v14081812","article-title":"The predictive role of hepatitis B biomarkers on HBV reactivation following direct-acting antiviral therapy in HBV\/HCV coinfected patients","volume":"14","author":"Tseng","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib19","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.3389\/fmicb.2018.01611","article-title":"When hepatitis B virus meets interferons","volume":"9","author":"Tan","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib20","doi-asserted-by":"crossref","first-page":"25946","DOI":"10.1074\/jbc.M115.657346","article-title":"The interferon-induced transmembrane proteins, IFITM1, IFITM2, and IFITM3 inhibit hepatitis C virus entry","volume":"290","author":"Narayana","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3390\/v11050427","article-title":"Human hepatitis B virus core protein inhibits IFNalpha-induced IFITM1 expression by interacting with BAF200","volume":"11","author":"Li","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib22","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jhep.2021.11.024","article-title":"How to achieve functional cure of HBV: stopping NUCs, adding interferon or new drug development?","volume":"76","author":"Wong","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib23","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.ajpath.2015.12.028","article-title":"Hepatic oncostatin M receptor beta regulates obesity-induced steatosis and insulin resistance","volume":"186","author":"Luo","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/hep.20086","article-title":"Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice","volume":"39","author":"Nakamura","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib25","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.yexcr.2003.09.002","article-title":"Induction and regulation of acute phase proteins in transdifferentiated hepatocytes","volume":"292","author":"Kurash","year":"2004","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1752-0509-3-40","article-title":"Narrative-based computational modelling of the Gp130\/JAK\/STAT signalling pathway","volume":"3","author":"Guerriero","year":"2009","journal-title":"BMC Syst Biol"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib27","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.3390\/ijms23063287","article-title":"Stimulation of osteoclast formation by oncostatin M and the role of WNT16 as a negative feedback regulator","volume":"23","author":"de Souza","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib28","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cytogfr.2015.07.006","article-title":"Oncostatin M and interleukin-31: Cytokines, receptors, signal transduction and physiology","volume":"26","author":"Hermanns","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.829923","article-title":"Regulation of pattern-recognition receptor signaling by HBX during hepatitis B virus infection","volume":"13","author":"You","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib30","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s41564-019-0421-x","article-title":"Decoding type I and III interferon signalling during viral infection","volume":"4","author":"Mesev","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib31","first-page":"803","article-title":"IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha","volume":"32","author":"Tsuno","year":"2009","journal-title":"J\u00a0Immunother"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib32","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.3390\/ijms20163859","article-title":"Analysis of IFITM-IFITM interactions by a flow cytometry-based FRET assay","volume":"20","author":"Winkler","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib33","article-title":"Differential transcriptomics analysis of IPEC-J2 cells single or coinfected with porcine epidemic diarrhea virus and transmissible gastroenteritis virus","volume":"13","author":"Song","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib34","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1038\/s41388-017-0096-9","article-title":"MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells","volume":"37","author":"Rajabi","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib35","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1136\/gutjnl-2019-319637","article-title":"Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription","volume":"69","author":"Salerno","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib36","first-page":"1335","article-title":"The guideline of prevention and treatment for chronic hepatitis B: a 2022 update","volume":"24","year":"2022","journal-title":"Chinese Society of Hepatology"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib37","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41423-020-00601-8","article-title":"Taurocholic acid inhibits the response to interferon-alpha therapy in patients with HBeAg-positive chronic hepatitis B by impairing CD8(+) T and NK cell function","volume":"18","author":"Xun","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jcmgh.2023.10.003_bib38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2016.10.008","article-title":"A\u00a0critical role of transcription factor YY1 in rheumatoid arthritis by regulation of interleukin-6","volume":"77","author":"Lin","year":"2017","journal-title":"J\u00a0Autoimmun"}],"updated-by":[{"DOI":"10.1016\/j.jcmgh.2024.03.007","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000}}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X23001820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X23001820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T03:21:20Z","timestamp":1707016880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X23001820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"alternative-id":["S2352345X23001820"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2023.10.003","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jcmgh.2024.03.007","asserted-by":"object"}]},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncostatin M Induces IFITM1 Expression to Inhibit Hepatitis B Virus Replication Via JAK-STAT Signaling","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2023.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}